about
Lipegfilgrastim in the management of chemotherapy-induced neutropenia of cancer patientsResults of multicenter double-blind placebo-controlled phase II clinical trial of Panagen preparation to evaluate its leukostimulatory activity and formation of the adaptive immune response in patients with stage II-IV breast cancerRole of lipegfilgrastim in the management of chemotherapy-induced neutropeniaTesting stem cell therapy in a rat model of inflammatory bowel disease: role of bone marrow stem cells and stem cell factor in mucosal regenerationA Comparison of Proposed Biosimilar LA-EP2006 and Reference Pegfilgrastim for the Prevention of Neutropenia in Patients With Early-Stage Breast Cancer Receiving Myelosuppressive Adjuvant or Neoadjuvant Chemotherapy: Pegfilgrastim Randomized OncologyGranulocyte colony-stimulating factor in the treatment of acute radiation syndrome: a concise review.Non-chemotherapy drug-induced agranulocytosis in a tertiary hospital.Quality Comparison of Biosimilar and Copy Filgrastim Products with the Innovator Product
P2860
Q26768126-14A77307-0887-46B4-A474-4656E9705EB5Q35194151-F29D73A8-7D0A-4EBC-87D5-3370BF268401Q35298321-25200362-2C11-435E-90AA-BD76620177EAQ35326009-6AE84AEB-8BB6-4207-A73F-58CD54E1FBF0Q37091148-AD7ACF8C-A98F-4CD2-8770-CBA72DAFCEAFQ38205372-7467A3CF-66CC-4858-AB1B-A2C0EBE38AD0Q40162078-3C53E735-4D2B-4A9A-8806-F8F12838B887Q57049370-2D78FBB5-7DCB-46A1-88E3-D86FFA6FB066
P2860
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
New G-CSF agonists for neutropenia therapy.
@en
type
label
New G-CSF agonists for neutropenia therapy.
@en
prefLabel
New G-CSF agonists for neutropenia therapy.
@en
P2860
P1476
New G-CSF agonists for neutropenia therapy.
@en
P2093
Jonathan Hoggatt
Louis M Pelus
P2860
P356
10.1517/13543784.2013.838558
P407
P577
2013-09-27T00:00:00Z